Challenges and controversies in immunization safety.

[1]  S. Plotkin,et al.  Field Evaluation of a Human Anthrax Vaccine. , 1962, American journal of public health and the nation's health.

[2]  F T Perkins,et al.  Safety of vaccines. , 1969, British medical bulletin.

[3]  W. Adler,et al.  Repeated immunization: possible adverse effects. Reevaluation of human subjects at 25 years. , 1974, Annals of internal medicine.

[4]  H. Freund,et al.  Etiologic and therapeutic aspects of intussusception in childhood. , 1977, American journal of surgery.

[5]  J A Bryan,et al.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. , 1979, American journal of epidemiology.

[6]  B. Culliton,et al.  Post-marketing surveillance. , 1980, British medical journal.

[7]  R. Holman,et al.  Guillain-Barré syndrome and the 1978-1979 influenza vaccine. , 1981, The New England journal of medicine.

[8]  L. Schonberger,et al.  Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. , 1982, JAMA.

[9]  P. Turnbull,et al.  Anthrax vaccines: past, present and future. , 1991, Vaccine.

[10]  J. Hughes,et al.  Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. , 1991, American journal of epidemiology.

[11]  J. W. Bass,et al.  Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988. , 1991, American journal of epidemiology.

[12]  J. Keyser,et al.  Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine , 1991, The Lancet.

[13]  H. Fineberg,et al.  Adverse Effects of Pertussis and Rubella Vaccines , 1991 .

[14]  G W Beran,et al.  Virus survival in the environment. , 1991, Revue scientifique et technique.

[15]  J. Ezzell,et al.  Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.

[16]  G. E. King,et al.  Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. , 1994, The Pediatric infectious disease journal.

[17]  M. Odent,et al.  Pertussis vaccination and asthma: is there a link? , 1994, JAMA.

[18]  S. Cochi,et al.  The Vaccine Adverse Event Reporting System (VAERS). , 1994, Vaccine.

[19]  R. Johnston,et al.  Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , 1994 .

[20]  M Rush,et al.  A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines , 1995, The Lancet.

[21]  B. P. Lewis,et al.  Combined Vaccines and Simultaneous Administration: Current Issues and Perspectives. Conference proceedings. Bethesda, Maryland, July 28-30, 1993. , 1995, Annals of the New York Academy of Sciences.

[22]  H Kunreuther,et al.  Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. , 1996, Journal of clinical epidemiology.

[23]  R. Dales,et al.  Framing effects on expectations, decisions, and side effects experienced: the case of influenza immunization. , 1996, Journal of clinical epidemiology.

[24]  P. Rodier,et al.  Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei , 1996, The Journal of comparative neurology.

[25]  S. Welkos,et al.  Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys , 1996 .

[26]  John W. Glasser,et al.  Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.

[27]  J. Böni,et al.  Reverse transcriptase activity in chicken embryo fibroblast culture supernatants is associated with particles containing endogenous avian retrovirus EAV-0 RNA , 1997, Journal of virology.

[28]  D. Classen,et al.  THE TIMING OF PEDIATRIC IMMUNIZATION AND THE RISK OF INSULIN-DEPENDENT DIABETES MELLITUS , 1997 .

[29]  N. Pearce,et al.  Is Infant Immunization a Risk Factor for Childhood Asthma or Allergy? , 1997, Epidemiology.

[30]  H. Pass,et al.  Simian virus 40, poliovaccines and human tumors: a review of recent developments , 1997, Oncogene.

[31]  M. Lewis,et al.  Parental perceptions of barriers to childhood immunization: results of focus groups conducted in an urban population. , 1997, Health education research.

[32]  M. Stoto,et al.  VACCINE SAFETY FORUM , 1997 .

[33]  S S Ellenberg,et al.  The complicated task of monitoring vaccine safety. , 1997, Public health reports.

[34]  B. Björkstén,et al.  A randomized controlled trial of the effect of pertussis vaccines on atopic disease. , 1998, Archives of pediatrics & adolescent medicine.

[35]  B. Schwartz,et al.  Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. American Academy of Pediatrics. , 1998, Pediatrics.

[36]  E. Miller,et al.  Impact of anti-vaccine movements on pertussis control: the untold story , 1998, The Lancet.

[37]  J. Goedert,et al.  Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. , 1998, JAMA.

[38]  O. Lyon-Caen,et al.  [Sclerotic plaques and vaccination against hepatitis B]. , 1998, Revue neurologique.

[39]  C. Lucy Park,et al.  Does Influenza Vaccination Exacerbate Asthma? , 1998, Drug safety.

[40]  T. Jefferson,et al.  No evidence that vaccines cause insulin dependent diabetes mellitus. , 1998, Journal of epidemiology and community health.

[41]  Roberta F. White,et al.  Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. , 1998, Environmental research.

[42]  J. Pope,et al.  The development of rheumatoid arthritis after recombinant hepatitis B vaccination. , 1998, The Journal of rheumatology.

[43]  C. Gillberg,et al.  MMR and Autism , 1998 .

[44]  A. Wakefield,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. , 1998, Lancet.

[45]  Robert T. Chen,et al.  Vaccine adverse events: causal or coincidental? , 1998, The Lancet.

[46]  P. Laforêt,et al.  Macrophagic myofasciitis: an emerging entity , 1998, The Lancet.

[47]  C Cox,et al.  Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. , 1998, JAMA.

[48]  R. Prislin,et al.  Immunization status and sociodemographic characteristics: the mediating role of beliefs, attitudes, and perceived control. , 1998, American journal of public health.

[49]  L. Magder,et al.  The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. , 1998, The New England journal of medicine.

[50]  R. Pounder,et al.  Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction , 1998, Journal of medical virology.

[51]  J. Leask,et al.  ‘An attempt to swindle nature’: press anti‐immunisation reportage 1993–1997 , 1998, Australian and New Zealand journal of public health.

[52]  R. Holman,et al.  Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. , 1998, The Pediatric infectious disease journal.

[53]  K. Mills,et al.  Distinct T‐cell subtypes induced with whole cell and acellular pertussis vaccines in children , 1998, Immunology.

[54]  N. Halsey,et al.  Limiting infant exposure to thimerosal in vaccines and other sources of mercury. , 1999, JAMA.

[55]  R W Ellis,et al.  New technologies for making vaccines. , 1999, Vaccine.

[56]  D Wood,et al.  Immunization registries in the United States: implications for the practice of public health in a changing health care system. , 1999, Annual review of public health.

[57]  Jun Li,et al.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association , 1999, The Lancet.

[58]  R. Glass,et al.  Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1999 .

[59]  N. Halsey.  Childhood immunizations and type 1 diabetes: summary of an Institute for Vaccine Safety Workshop. The Institute for Vaccine Safety Diabetes Workshop Panel. , 1999, The Pediatric infectious disease journal.

[60]  Rinkevich.  Invertebrates versus Vertebrates Innate Immunity: In the Light of Evolution (‘Nothing in biology makes sense except in the light of evolution’ T. Dobzhansky, Amer Biol Teacher 1973;35:125–9) , 1999, Scandinavian journal of immunology.

[61]  Philip K. Russell,et al.  Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 1999, JAMA.

[62]  W. Heneine,et al.  Evidence of Avian Leukosis Virus Subgroup E and Endogenous Avian Virus in Measles and Mumps Vaccines Derived from Chicken Cells: Investigation of Transmission to Vaccine Recipients , 1999, Journal of Virology.

[63]  R. Mahoney,et al.  The introduction of new vaccines into developing countries. , 1999, Vaccine.

[64]  Robert W Pinner,et al.  Bioterrorism alleging use of anthrax and interim guidelines for management--United States, 1998. , 1999, MMWR. Morbidity and mortality weekly report.

[65]  L Phillips,et al.  Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. , 1999, JAMA.

[66]  G. W. Parker,et al.  Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. , 1999, JAMA.

[67]  A. Hall,et al.  Multiple sclerosis and hepatitis B vaccine? , 1999, Vaccine.

[68]  P. Finn,et al.  Immune mechanisms of childhood asthma , 1999, Thorax.

[69]  A. Krieg,et al.  Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. , 1999, Seminars in arthritis and rheumatism.

[70]  R. Chen,et al.  Vaccine risks: real, perceived and unknown. , 1999, Vaccine.

[71]  J. Tuomilehto,et al.  Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study , 1999, BMJ.

[72]  H. Guess,et al.  Combination vaccines: issues in evaluation of effectiveness and safety. , 1999, Epidemiologic reviews.

[73]  J. Butel,et al.  Response: More About: Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease. , 2000, Journal of the National Cancer Institute.

[74]  G. Gray,et al.  Surveillance for adverse events associated with anthrax vaccination--U.S. Department of Defense, 1998-2000. , 2000, MMWR. Morbidity and mortality weekly report.

[75]  P. Laforêt,et al.  Gallium-67 scintigraphy in macrophagic myofasciitis. , 2000, Arthritis and rheumatism.

[76]  W. Sexson,et al.  Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. , 2000, The Journal of pediatrics.

[77]  H. Bedford,et al.  Concerns about immunisation , 2000, BMJ : British Medical Journal.

[78]  M. Hotopf,et al.  Role of vaccinations as risk factors for ill health in veterans of the Gulf war : cross sectional study , 2018 .

[79]  O. Heinonen,et al.  Measles history and atopic diseases: a population-based cross-sectional study. , 2000, JAMA.

[80]  Malbea A Lapete,et al.  Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .

[81]  G. Rook,et al.  Give us this day our daily germs. , 1998, Biologist.

[82]  C. Berg,et al.  Abortion surveillance--United States, 1999. , 2002, Morbidity and mortality weekly report. Surveillance summaries.